The EU approval of DAWNZERA is an important milestone that reflects our ongoing commitment to bring this innovative medicine to people in need across the globe
The partnership aims to fuse Avantium’s breakthrough materials with Packamama’s expertise in low-emission, innovative wine bottles
Transcenta will grant EirGenix a non-exclusive license to its Highly Intensified Continuous Bioprocessing (HiCB) platform
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
Biogen paid Ionis a US $ 60 million one-time upfront payment
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
Dawnzera demonstrated significant and sustained HAE attack rate reduction and long-term disease control
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
Subscribe To Our Newsletter & Stay Updated
